Phillip L. Palmbos

Also affiliated with University Health System, Michigan Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer”.

A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0024

N/A

1.7DataRank · unranked

59 citations

Stephanie Daignault‐Newton, Scott A. Tomlins, Neeraj Agarwal, Przemyslaw Twardowski, Alicia K. Morgans +11 more

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

International Journal of Molecular Sciences(2021)10.3390/ijms23010004

N/A

0DataRank · unranked

13 citations

Tadas Kasputis, Srinivas Nallandhighal, Sophia M. Abusamra, Amy Kasputis, Saloni Haruray +12 more

TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.

Research Square(2023)10.21203/rs.3.rs-3697712/v1

N/A

0DataRank · unranked

2 citations

Yin Wang, Nicole A. Jerome, Alan Kelleher, Marian L. Henderson, Mark L. Day +2 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response

European Urology(2024)10.1016/j.eururo.2024.05.026

N/A

0DataRank · unranked

20 citations

Samuel D. Kaffenberger, Liwei Bao, Nathalie M. Vandecan, Laura Goo, Athena Apfel +23 more

Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics

Neoplasia(2024)10.1016/j.neo.2024.101036

N/A

0DataRank · unranked

10 citations

Molly Kozminsky, Kathleen C. Day, Luke J. Broses, Marian L. Henderson, Christopher Patsalis +10 more

Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing

Urology Practice(2024)10.1097/upj.0000000000000727

N/A

0DataRank · unranked

2 citations

Marissa A. Solorzano, Jake Quarles, Mallory Luke, Milan Patel, Randy Vince +15 more

TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion

Oncogene(2025)10.1038/s41388-025-03557-z

N/A

0DataRank · unranked

3 citations

Nicole A. Jerome, Alan Kelleher, Marian L. Henderson, Mark L. Day, Pierre A. Coulombe +2 more

The molecular mechanism of ambrosin-induced cytotoxicity of human breast cancer and bladder cancer cells

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.110531

N/A

0DataRank · unranked

0 citations

John R. Rubin, Luke J. Broses, Christopher Patsalis, Marian L. Henderson, Steven James Wilson +18 more